MTA taps Respira, HomeSleep for sleep screening, treatment
By HME News Staff
Updated Thu February 9, 2017
PARAMUS, N.J. - The board of the Metropolitan Transportation Authority of New York has awarded Respira-HomeSleep a contract to provide medical services to screen, treat, manage and monitor select MTA employees for obstructive sleep apnea. “We look forward to collaborating with HomeSleep and local DME companies in creating this groundbreaking model of care for the transportation industry,” said Yolanda Mara Martinez, founder and CEO of Respira. Respira is a respiratory therapy, sleep medicine, DME and healthcare management company. Its custom-tailored programs serve more than 80,000 patients. HomeSleep is a sleep diagnostics company, providing home sleep testing devices to patients in their homes to diagnose OSA. “We have put a tremendous amount of time and effort into building a comprehensive sleep program with the Respira team and are confident that together we can assist the MTA and their employees,” said Jonathan Perrone, founder and CFO of HomeSleep.
Comments